Futura Medical’s Eroxon® Hits U.S. Market
Company Announcements

Futura Medical’s Eroxon® Hits U.S. Market

Futura Medical (GB:FUM) has released an update.

Futura Medical PLC has announced the pre-order availability of its leading sexual health product, Eroxon®, on Amazon, with delivery expected in October 2024. Additionally, the product will hit U.S. store shelves in the same month. Eroxon® is a clinically proven, fast-acting topical gel for the treatment of erectile dysfunction, offering a unique over-the-counter solution in the sexual health market.

For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskFutura Medical Executives Adjust Shareholdings
TipRanks UK Auto-Generated NewsdeskFutura Medical Projects Rising Revenues with Eroxon®
TipRanks UK Auto-Generated NewsdeskFutura Medical’s Profit Surge on Eroxon® Success
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App